Growth Metrics

Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2025)

Legend Biotech (LEGN) posted Asset Utilization Ratio of 0.6 for Q4 2025, up 11.74% on a QoQ basis from 0.53 in Q3 2025, and up 62.08% year-over-year from 0.37 in Q4 2024.

Legend Biotech (LEGN) has 6 years of Asset Utilization Ratio data on file, last reported at 0.6 in Q4 2025.

  • In Q4 2025, Asset Utilization Ratio rose 62.08% year-over-year to 0.6; the TTM figure through Dec 2025 stood at 0.6 (up 62.08% YoY), while the FY2025 annual figure was 0.6, up 69.56% from the prior year.
  • Asset Utilization Ratio advanced to 0.6 in Q4 2025, from 0.53 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 45.22 in Q3 2024 and bottomed at 0.0 in Q1 2021.
  • A 5-year average of 10.6 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2021 — Asset Utilization Ratio soared 147728.61% — and 2024, when it slumped 99.15%.
  • Year by year, Asset Utilization Ratio stood at 0.09 in 2021, then climbed by 25.53% to 0.12 in 2022, then surged by 36951.55% to 43.21 in 2023, then slumped by 99.15% to 0.37 in 2024, then jumped by 62.08% to 0.6 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.6 (Q4 2025), 0.53 (Q3 2025), and 0.48 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.60
Sep 30, 2025 0.53
Jun 30, 2025 0.48
Mar 31, 2025 0.44
Dec 31, 2024 0.37
Sep 30, 2024 45.22
Jun 30, 2024 44.69
Mar 31, 2024 44.00
Dec 31, 2023 43.21
Sep 30, 2023 0.12
Jun 30, 2023 0.10
Mar 31, 2023 0.08
Mar 31, 2022 0.12
Dec 31, 2021 0.09
Sep 30, 2021 0.11
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.00
Sep 30, 2020 0.00